Skip to main content

Table 2 HDACis in clinical trials for leukemia

From: Histone acetylation: novel target for the treatment of acute lymphoblastic leukemia

Chemical structure Name Target Study phase
Hydroxamates SAHA (vorinostat) Pan-inhibitor Phase I/II alone or in combination
PXD101 (belinostat) Pan-inhibitor Phase I/II alone or in combination
LBH589 (panobinostat) Pan-inhibitor Phase I/II alone or in combination
Cyclic peptides Depsipeptide/FK228 (romidepsin) Classes I Phase I/II alone or in combination
Aliphatic fatty acids Valproic acid Classes I and IIa Phase II alone or in combination
Butyrate Pan-inhibitor Phase I/II alone or in combination
Benzamides MS-275 (entinostat) Class I Phase I alone or in combination
MGCD0103 (mocetinostat) Class I/IV Phase I alone or in combination
  1. HDACis HDAC inhibitors